新闻
10 小时之前
Lexeo Therapeutics Announces Progress in FDA Discussions for Accelerated Approval Pathway and Positive Interim Clinical Data for LX2006 in Friedreich Ataxia Cardiomyopathy
临床结果快速通道孤儿药突破性疗法
10 小时之前
Jade Biosciences Announces JADE201, a Potentially Best-in-Class Half-Life Extended Afucosylated Anti-BAFF Receptor Monoclonal Antibody in Development for Autoimmune Diseases
免疫疗法临床结果细胞疗法
10 小时之前
快速通道孤儿药
10 小时之前
Marker Therapeutics Announces First Patient Treated in Off-the-Shelf Program
细胞疗法免疫疗法临床结果
10 小时之前
引进/卖出基因疗法临床研究
10 小时之前
Atea Pharmaceuticals to Present New Data Supporting Combination of Bemnifosbuvir and Ruzasvir as Potential Best-in-Class Regimen for Treatment of Hepatitis C Virus Infection at The Liver Meeting® 2025
临床结果
10 小时之前
Neurogastrx to Present Proof-of-Concept Clinical Data on Oral Candidate NG101 to Reduce Nausea & Vomiting Associated with GLP-1 Agonists at ObesityWeek®
10 小时之前
Skye Bioscience Reports Topline CBeyond™ Phase 2a Data from Nimacimab Monotherapy and Combination Clinical Trial
临床结果
细胞疗法引进/卖出基因疗法免疫疗法